-
COVER STORY
Grifols – A reliable and trusted partner in the injectable field
-
PHARMA KEY TRENDS
What’s trending in pharma: a top 10 watch list for 2019
P. Van Arnum
-
A WORD WITH
Dr. Michael Quirmbach, Chief Business Officer – CordenPharma International
-
PERSONALISED MEDICINES
Collaboration as the Best Medicine
J. S. Srai, C. Badman
-
A WORD WITH
Judy Zhu, Member of the Board and General Manager – Nanjing Dorra Pharma
-
MARKETPLACE
Impact of Brexit on the European Chemical Industry
R. van Sloten
-
COMPANY PROFILE
Cerbios-Pharma – Moving along with ADCs: a CDMO perspective
V. Sousa
-
OLIGOS & PEPTIDES
Jetting manufacturing of resins for solid-phase peptide synthesis
O. Al Musaimi, S. Serban, Y. E. Jad, Z. Ma, A. Kumar, C. Ji, B. G. De La Torre, A. Basso, F. Albericio
-
COMPANY PROFILE
Indena enhances its custom services thanks to new advanced technology
-
PHARMA AND CHEMICAL SUPPLY CHAIN
Panel Discussion on Pharma and Chemical Supply Chain – Commentary article
M. Quirmbach
-
Panel Discussion on Pharma and Chemical Supply Chain
-
COMPANY PROFILE
Olon…..all in one!
-
SUSTAINABILITY/GREEN CHEMISTRY
Polarclean from waste valorization of Nylon 66 manufacturing: a sustainable solvent for organic synthesis
L. Vaccaro, S. Santoro, L. Luciani, C. Melone, F. Ferlin
-
A WORD WITH
Luca Porcu, Fine Chemicals Director – ANGELINI
-
COLUMN: BIOMATERIALS & NANOMATERIALS
Hydrogen peroxide: from centralized to decentralized and clean production
M. Pagliaro
-
COMPANY PROFILE
“Quality by Design” applied to Development and Manufacturing at Procos
-
Column: REGULATION
Brexit and REACH: an overview for a worst case scenario (no deal)
A. Conto
-
ANALYTICAL TECHNOLOGY
The role of new molecular technologies in improving laboratory productivity
N. Pavlidis
-
BIOCIDES
Cleaning and disinfection program part of the lifecycle approach: a risk based rather arbitrarily imposed approach
W. El Azab
-
EVENTS
DCAT Week ’19: Business Development Opportunities. Valuable Networking. Timely Education.
-
A WORD WITH
Paolo Magrì, President at DCAT (Drug, Chemical and Associated Technologies Association)
-
COLUMN: MERGERS AND ACQUISITIONS
New year rings in return to big deals as M&A engine fires up
M. Powers
-
COLUMN: INTELLECTUAL PROPERTY
Biotechnology and patents: focus on monoclonal antibodies
G. Tagliafico, S. Venturini
